1YR企业会员
英文名称 | 中文名称 | CAS |
---|---|---|
Lidocaine EP Impurity H | 2,6-二甲基氯代乙酰苯胺 | 1131-01-7 |
Omeprazole Impurity E | 奥美拉唑 N-氧化物 | 176219-04-8 |
Tofacitinib Impurity S | 托伐替尼杂质S | |
Bedaquiline Impurity 1 | 贝达喹啉杂质 | 861709-47-9 |
Tofacitinib Impurity T | 托伐替尼杂质T | |
Tofacitinib Impurity 66 | (3S,4S)-1-苄基-N,4-二甲基哌啶-3-胺 | 477600-69-4 |
Tofacitinib | 托法替尼 | 477600-75-2 |
Tofacitinib Impurity I | 托法替尼杂质I (3S,4S) | |
Omeprazole Impurity 20 | 1H-Benzimidazole, 5-methoxy-1-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]thio]- | 1346600-29-0 |
Tofacitinib Impurity 68 | 托法替尼杂质68 | |
Tofacitinib Impurity 73 | 托法替尼杂质73 | |
Tofacitinib Impurity 82 | 托法替尼杂质82 | |
Tofacitinib Impurity 93 | 托法替尼杂质93 | |
Tofacitinib Impurity C(Citrate) | 3-[(3S,4S)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile | 2174011-55-1 |
Tofacitinib Impurity J | 枸橼酸托法替布H039-M2-I2 | 2097982-05-1 |
Omeprazole Impurity 15 | 2-氯甲基-4-氯-3,5-二甲基吡啶 | 142885-96-9 |
Dapagliflozin Impurity 43 | (5-碘-2-氯苯基)(4-乙氧基苯基)甲酮 | 1103738-26-6 |
Tofacitinib Impurity L | 托法替尼杂质 | 477600-76-3 |
5-O-Desmethyl Omeprazole | 5-O-去甲基奥美拉唑 | 151602-49-2 |
Bedaquiline Impurity 2 | 3-苄基-2-甲氧基喹啉 | 1381767-10-7 |
Tofacitinib Impurity 99 | 托法替尼杂质 | 2227199-31-5 |
Tofacitinib Impurity 70 | 托法替尼杂质70 | |
Tofacitinib Impurity 90 | 托法替尼杂质90 | |
Tofacitinib Impurity 98 | 托法替尼杂质98 | |
Valproate Sodium Impurity 10 | 丙戊酸钠杂质10 | |
Omeprazole Impurity 23 | 2,3,5-三甲基吡啶氧化物 | 74409-42-0 |
Esomeprazole Impurity J | (S)-4-去甲氧基-4-氯奥美拉唑 | 863029-89-4 |
Omeprazole Impurity J | 2-氯甲基-3,5-二甲基-4-甲氧基吡啶盐酸盐 | 86604-75-3 |
Tofacitinib Impurity 1 | 4-氯-7-甲苯磺酰基-7H-吡咯[2,3-D]嘧啶 | 479633-63-1 |
Cefixime EP Impurity C | 头孢克肟杂质C | |
Tofacitinib Impurity B | (3S,4R)-4-甲基-3-(甲基-7H-吡咯并[2,3-D]嘧啶-4-氨基)-BETA-氧代-1-哌啶丙腈 | 1092578-48-7 |
Tofacitinib Impurity G | 托法替尼杂质 | 1616761-00-2 |
Tofacitinib Impurity 67 | 托法替尼杂质67 | |
Valproate Sodium Impurity 6 | 丙戊酸钠杂质14 | 258264-00-5 |
Valproate Sodium EP Impurity J | 丙戊酸钠杂质J | 5340-48-7 |
Omeprazole Impurity 19 | 4-甲氧基-2,3,5-三甲基吡啶 | 109371-19-9 |
Omeprazole Impurity K | 4-硝基-2,3,5-三甲基吡啶-N-氧化物 | 86604-79-7 |
Valproate Sodium EP Impurity D | 丙戊酸钠杂质D | 52061-75-3 |
Tofacitinib Impurity W | 托法替尼杂质W | |
Tofacitinib Impurity X | 托法替尼杂质X | |
Tofacitinib Impurity 69 | 托法替尼杂质69 | |
Tofacitinib Impurity 74 | 托法替尼杂质74 | |
Tofacitinib Impurity 83 | 托法替尼杂质83 | |
Tofacitinib Impurity 94 | 托法替尼杂质94 | |
Dapagliflozin Hydroperoxide Impurity | 达格列净杂质41 | 2452300-94-4 |
Omeprazole Impurity 27 | 4-羟基奥美拉唑 | 301669-82-9 |
Esomeprazole Impurity C | 奥美拉唑硫醚 | 73590-85-9 |
Omeprazole Impurity 25 | (R)-奥美拉唑 | 119141-89-8 |
Tofacitinib Impurity 4 | N-甲基-N-((3R,4R)-4-甲基-1-苄基-3-哌啶基)-7-((4-甲基苯基)磺酰基)7H-吡咯并[2,3-D]嘧啶-4-胺 | 923036-30-0 |
Omeprazole Impurity 21 | 4-甲氧基-2-硝基乙酰苯胺 | 119-81-3 |
Tofacitinib Impurity 17 | 托法替尼氢化杂质 | 1812890-23-5 |
Dapagliflozin Impurity G | 达格列净杂质B | 2169998-23-4 |
Tofacitinib Impurity 71 | 托法替尼杂质71 | |
Tofacitinib Impurity 79 | 托法替尼杂质79 | |
Bedaquiline Impurity 3 | Bedaquiline Impurity 14 | 654654-93-0 |
Tofacitinib Impurity 114 | Tofacitinib Impurity 114 | |
Valproate Sodium EP Impurity F | 丙戊酰胺 | 2430-27-5 |
Tofacitinib Impurity 76 | (4-甲基吡啶-3-基)氨基甲酸甲酯 | 694495-63-1 |
Omeprazole Impurity 14 | 4-甲氧基-2,3,5-三甲基吡啶氮氧化物 | 86604-80-0 |
Omeprazole Impurity F | 奥美拉唑EP杂质F | 125656-82-8 |
Esomeprazole Impurity I | 埃索美拉唑杂质I | 158812-85-2 |
Valproate Sodium EP Impurity K | ||
Tofacitinib Impurity A | (3R,4S)-4-甲基-3-(甲基-7H-吡咯并[2,3-D]嘧啶-4-氨基)-BETA-氧代-1-哌啶丙腈 | 1092578-46-5 |
Tofacitinib Impurity 78 | 托法替尼中间体VI | 1206875-41-3 |
Dapagliflozin Impurity 4 | (2S,3R,4R,5S,6R)-2-(4-氯-3 - ((4-乙氧基苯基)(羟基)甲基)苯基)-6 | 1204222-85-4 |
Tofacitinib Impurity U | 托伐替尼杂质U | |
Omeprazole Impurity 22 | 4-甲氧基邻苯二胺 | 102-51-2 |
Dapagliflozin Dimer | 达格列净二聚体 | |
Tofacitinib Impurity V | 托法替尼杂质V | |
Tofacitinib Impurity K | 托法替尼杂质 | 2227197-38-6 |
Valproate Sodium Impurity 8 | 丙戊酸钠杂质8 | |
Tofacitinib Impurity 97 | ||
Tofacitinib Impurity 80 | 托伐替尼杂质80 | |
Valproate Sodium EP Impurity I | 2-丙基戊腈 | 13310-75-3 |
Tofacitinib Impurity P | Tofacitinib Impurity K | 2328165-36-0 |
Lidocaine EP Impurity C | 利多卡因杂质D | 7728-40-7 |
Omeprazole Impurity 17 | 2-氯甲基-3,5-二甲基-4-硝基吡啶 | 153476-68-7 |
Cefixime Impurity A | 头孢克肟杂质A | 1614255-90-1 |
Valproate Sodium Impurity 20 | 2-丙基己酸 | 3274-28-0 |
Tofacitinib Impurity 84 | 托法替尼杂质84 | |
Tofacitinib Impurity 95 | 托法替尼杂质95 | |
Cefixime EP Impurity B | 头孢克肟杂质B | 1335475-19-8 |
Tofacitinib Impurity H | 托法替尼杂质H (3S,4S) | |
Omeprazole Impurity 18 | 2-氯甲基-4-氯-3,5-二甲基吡啶盐酸盐 | 143016-68-6 |
Omeprazole Impurity L | 2-(乙酰氧基甲基)-4-甲氧基-3,5-二甲基吡啶 | 91219-90-8 |
Tofacitinib Impurity 96 | 托法替尼杂质24 | 2028267-73-2 |
Dapagliflozin alfa-Isomer | 达格列净杂质G | 1373321-04-0 |
Tofacitinib Impurity 72 | 托法替尼杂质72 | |
Omeprazole Impurity D | 奥美拉唑杂质A | 88546-55-8 |
Tofacitinib Impurity 6 | 4-氯吡咯并嘧啶 | 3680-69-1 |
Cefixime Impurity 15 | 7-氨基-3-氯-3-头孢烯-4-羧酸对硝基苄基酯盐酸盐(RC) | 53483-70-8 |
Omeprazole Impurity 24 | 3,5-二甲基-4-硝基吡啶 1-氧化物 | 14248-66-9 |
Tofacitinib Impurity 75 | 3-氨基-4-甲基吡啶 | 3430-27-1 |
Tofacitinib Citrate | 枸橼酸托法替尼 | 540737-29-9 |
Omeprazole Impurity B | 埃索美拉唑杂质B | 110374-16-8 |
Tofacitinib Impurity N | 托法替尼杂质 6 | 1640972-35-5 |
Dapagliflozin Impurity 10 | 达格列净杂质14 | 2271248-78-1 |
Omeprazole Impurity G | 奥美拉唑EP杂质G | 125656-83-9 |
Tofacitinib Impurity 3 | Tofacitinib Impurity 3 | 1206825-36-6 |
Tofacitinib Impurity 89 | 托法替尼杂质89 |
联系方式
电话:
邮箱:sale@hdimpurity.com
网址: https://www.hdimpurity.com/
产品总数: 3418
地址:
CB指数:58
国籍:中国